Abstract
Transgenic technology has huge application potential in agriculture and medical fields, such as producing new livestock varieties with new valuable features and xenotransplantation. However, how an exogenous gene affects the host animal’s gene regulation networks and their health status is still poorly understood. In the current study, Fat-1 transgenic sheep were generated, and the tissues from 100-day abnormal (DAF_1) and normal (DAF_2) fetuses, postnatal lambs (DAF_4), transgenic-silencing (DAFG5), and -expressing (DAFG6) skin cells were collected and subjected to transcriptome sequencing, and their gene expression profiles were compared in multiple dimensions. The results were as follows. For DAF_1, its abnormal development was caused by pathogen invasion but not the introduction of the Fat-1 gene. Fat-1 expression down-regulated the genes related to the cell cycle; the NF-κB signaling pathway and the PI3K/Akt signaling pathway were down-regulated, and the PUFAs (polyunsaturated fatty acids) biosynthesis pathway was shifted toward the biosynthesis of high-level n-3 LC-PUFAs (long-chain PUFAs). Four key node genes, FADS2, PPARA, PRKACA, and ACACA, were found to be responsible for the gene expression profile shift from the Fat-1 transgenic 100-day fetus to postnatal lamb, and FADS2 may play a key role in the accumulation of n-3 LC-PUFAs in Fat-1 transgenic sheep muscle. Our study provides new insights into the FUFAs synthesis regulation in Fat-1 transgenic animals.
Highlights
Transgenic animals can be defined as animals in which new or altered genes have been experimentally inserted into their genome by genetic engineering techniques [1]
The results showed that all these fetuses expressed Fat-1 in their tissues (Figure 1c, Table S1), which indicated a successful transgenic animal production workflow
The results showed that the percentages of those polyunsaturated fatty acids (PUFAs) in the n-6 PUFAs biosynthesis pathway, including LA, γ-linolenic acid (GLA, 18:3n-6), dihomo-γ-linolenic acid (DGLA, 20:3n-6), and ARA, were significantly reduced in transgenic fetuses, while for the PUFAs in the n-3 PUFAs biosynthesis pathway, n-3 LC-PUFAs EPA and DHA were significantly increased. (Figure 6b,c)
Summary
Transgenic animals can be defined as animals in which new or altered genes have been experimentally inserted into their genome by genetic engineering techniques [1]. Wilmut I. and colleagues took the lead in producing the world’s first somatic cell cloned sheep, Dolly, in 1997, which pioneered a new era of mammalian somatic cell cloning, bridged the gap between animal cell manipulation and individual manipulation, and injected new vitality into animal transgenic technology research [3]. In 2004, Kuroiwa reported the production of transgenic cattle unsusceptible to mad cow disease [7]. These studies demonstrated the power of transgenic cloning technologies in the producing of new livestock varieties with great new features and high economic values
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have